Denis Villeneuve’s ‘Dune’ premieres at Venice, sequel could be in the works
The Hindu
The sci-fi epic, starring Timothée Chalamet, Zendaya and Oscar Isaac among others, is set to be released on Oct. 22, simultaneously in theaters and on HBO Max
Denis Villeneuve’s adaption of Frank Herbert’s “Dune” was always envisioned as two films. But even if the sequel is anything but a certainty, it’s already been a “dream” for the Canadian director and his star Timothée Chalamet. “Simply put, this was the honor of a lifetime for me,” Chalamet said Friday at the Venice Film Festival. “I hope we get to do a second one. It would be a dream...(but) it’s already been a dream come true.” .
Inspired by deeply personal memories, says maker of Telugu short selected for Sundance Film Festival
Telugu short film "O’sey Balamma," inspired by childhood memories, selected for Sundance Film Festival 2026, says creator Nimmala Raman.

In Episode 13 of Frequently Made Mistakes, we tackle one of the biggest traps in modern action filmmaking: confusing scale for stakes. Explosions get bigger. The threat goes global. But the emotional cost never changes. Using examples from Tiger 3, Casino Royale, Mission Impossible: Fallout, and Bajrangi Bhaijaan, this episode breaks down why raising scale does not automatically raise stakes — and how it often dilutes drama instead. We look at:

In a few days, there would be a burst of greetings. They would resonate with different wavelengths of emotion and effort. Simple and insincere. Simple but sincere. Complex yet insincere. Complex and sincere. That last category would encompass physical greeting cards that come at some price to the sender, the cost more hidden than revealed. These are customised and handcrafted cards; if the reader fancies sending them when 2026 dawns, they might want to pick the brains of these two residents of Chennai, one a corporate professional and the other yet to outgrow the school uniform

‘Pharma’ series review: Despite strong performances and solid premise, the narrative misses the mark
Pharma offers strong performances but falters in storytelling, making it a passable watch despite its intriguing premise.









